Yu‐Feng Lin

机构：Asia University, Chinese University of Hong Kong, Guangdong Pharmaceutical University, First Affiliated Hospital of Guangdong Pharmaceutical University, Hunan Entry-Exit Inspection and Quarantine Bureau · ORCID：0000-0003-1998-3310

发表论文 28 篇 · 总被引 635 次 · h-index 13

代表论文

• MIB2: metal ion-binding site prediction and modeling server (2022 · Bioinformatics · 被引 152)
• Prediction of Metal Ion–Binding Sites in Proteins Using the Fragment Transformation Method (2012 · PLoS ONE · 被引 147)
• Understanding the functional properties of bio-inorganic nanoflowers as biocatalysts by deciphering the metal-binding sites of enzymes (2017 · Journal of Materials Chemistry B · 被引 64)
• lncRNA HAND2-AS1 Inhibits Liver Cancer Cell Proliferation and Migration by Upregulating SOCS5 to Inactivate the JAK-STAT Pathway (2020 · Cancer Biotherapy and Radiopharmaceuticals · 被引 36)
• Recognition of a Novel Gene Signature for Human Glioblastoma (2022 · International Journal of Molecular Sciences · 被引 30)
• Protegrin-1 inhibits porcine ovarian granulosa cell apoptosis from H2O2-induced oxidative stress via the PERK/eIF2α/CHOP signaling pathway in vitro (2021 · Theriogenology · 被引 30)